Zhengwei Tu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhengwei Tu has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Feifei Xu
3 shared publications- Wenfeng Gou
Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College
3 shared publications Ao Wang
2 shared publications- Wenbin Hou
Institute of Radiation Medicine, Peking Union Medical College & Chinese Academy of Medical Sciences, Tianjin, China
2 shared publications Xuefei Wang
2 shared publicationsYanli Li
2 shared publications
Latest Publications
- Open Access
- 28 May 2026
- Published by Elsevier in SSRN Electronic Journal
The METTL3/IGF2BP2/Bim Axis Alleviates Acute Pancreatitis by Suppressing cGAS-STING Pathway
Background: Increasing evidence indicates that N6-methyladenosine (m6A), as one of the common RNA modifications, plays a significant role in inflammatory diseases. However, the specific role of m6A in the occurrence and development of acute pancreatitis remains unclear. This study investigated the role of m6A modifications mediated by METTL3 and IGF2BP2 in acinar cells during acute pancreatitis. Methods: The expression of METTL3 and the m6A modification level in pancreatic tissues and acinar cells from the control and pancreatitis groups were verified using qRT-PCR, western blotting, etc. The differentially expressed m6A-modified genes during pancreatitis were identified through methylation RNA immunoprecipitation sequencing (meRIP-seq). Using RNA immunoprecipitation (RIP) and luciferase activation assays, the recognition role of IGF2BP2 in the m6A modification sites of Bim was verified. Findings: We found that METTL3 is significantly up-regulated, resulting in an increase in m6A methylation of Bim mRNA. This m6A modification, recognized by the “reader” IGF2BP2, enhances Bim mRNA stability, consequently elevating the protein levels of its downstream effectors, BAX and BAK1. The up-regulation of these proteins triggers mitochondrial DNA release into the cytosol. The liberated mtDNA subsequently activates the cGAS/STING/NF-κB signaling pathway, exacerbating pancreatic injury. Inhibition of METTL3 with STM2457 effectively mitigated this cascade and alleviated pancreatic damage. Interpretation: Our findings highlight the METTL3/IGF2BP2/Bim axis as a promising therapeutic target for acute pancreatitis.
- 28 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessThe METTL3/IGF2BP2/Bim Axis Alleviates Acute Pancreatitis by Suppressing cGAS-STING Pathway
Background: Increasing evidence indicates that N6-methyladenosine (m6A), as one of the common RNA modifications, plays a significant role in inflammatory diseases. However, the specific role of m6A in the occurrence and development of acute pancreatitis remains unclear. This study investigated the role of m6A modifications mediated by METTL3 and IGF2BP2 in acinar cells during acute pancreatitis. Methods: The expression of METTL3 and the m6A modification level in pancreatic tissues and acinar cells from the control and pancreatitis groups were verified using qRT-PCR, western blotting, etc. The differentially expressed m6A-modified genes during pancreatitis were identified through methylation RNA immunoprecipitation sequencing (meRIP-seq). Using RNA immunoprecipitation (RIP) and luciferase activation assays, the recognition role of IGF2BP2 in the m6A modification sites of Bim was verified. Findings: We found that METTL3 is significantly up-regulated, resulting in an increase in m6A methylation of Bim mRNA. This m6A modification, recognized by the “reader” IGF2BP2, enhances Bim mRNA stability, consequently elevating the protein levels of its downstream effectors, BAX and BAK1. The up-regulation of these proteins triggers mitochondrial DNA release into the cytosol. The liberated mtDNA subsequently activates the cGAS/STING/NF-κB signaling pathway, exacerbating pancreatic injury. Inhibition of METTL3 with STM2457 effectively mitigated this cascade and alleviated pancreatic damage. Interpretation: Our findings highlight the METTL3/IGF2BP2/Bim axis as a promising therapeutic target for acute pancreatitis.
- Top Cited PapersOpen Access
- 10 February 2025
- Published by Elsevier in Phytomedicine
- Vol. 139, 156424
Qingyi decoction and its active ingredients ameliorate acute pancreatitis by regulating acinar cells and macrophages via NF-κB/NLRP3/Caspase-1 pathways
- 10 February 2025
- Published by Elsevier in Phytomedicine
- Vol. 139, 156424
Top Cited PapersOpen AccessQingyi decoction and its active ingredients ameliorate acute pancreatitis by regulating acinar cells and macrophages via NF-κB/NLRP3/Caspase-1 pathways
- 19 June 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 137, 112418
Naringin dihydrochalcone alleviates sepsis-induced acute lung injury via improving gut microbial homeostasis and activating GPR18 receptor
- 19 June 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 137, 112418
Naringin dihydrochalcone alleviates sepsis-induced acute lung injury via improving gut microbial homeostasis and activating GPR18 receptor
- 28 March 2023
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 311, 116428
Protective effect of total flavonoids of Engelhardia roxburghiana Wall. leaves against radiation-induced intestinal injury in mice and its mechanism
- 28 March 2023
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 311, 116428
Protective effect of total flavonoids of Engelhardia roxburghiana Wall. leaves against radiation-induced intestinal injury in mice and its mechanism